Asim Shah, MD, and Syed Z. Iqbal, MD, discuss the use of paliperidone to treat adult patients with schizophrenia.
Researchers weigh in on the use of placebo-controlled trials in schizophrenia.
Investigators found data that showed a ghrelinergic signaling mechanism may be responsible for increased appetite in patients with MDD.
A newly established center at Johns Hopkins is reinvigorating research on the potential therapeutic applications of psychedelics.
Depression is a common comorbidity among patients with chronic pain, and the use of antidepressants may alleviate symptoms of both disorders.